Your browser doesn't support javascript.
loading
[Guideline for clinical comprehensive evaluation of Chinese patent medicine (2022 version)].
Yuan, Wei-An; Zhang, Jun-Hua; Liu, Jian-Ping; Yang, Zhong-Qi; Cao, Jun-Ling; Liao, Xing; Xi, Xiao-Yu; Han, Mei; Li, Wen-Yuan; Qiu, Zhen-Wen; Feng, Shi-Yin; Guo, Yuan-Yuan; Cao, Lu-Jia; Liao, Xiao-Hong; Ai, Yan-Ling; Huang, Ju; Jia, Lu-Lu; Su, Xiang-Fei; Wu, Xue; Dai, Ze-Qi; Guo, Ji-Hua; Lu, Bing-Qing; Zhang, Xiao-Xiao; Tang, Jian-Yuan.
Affiliation
  • Yuan WA; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai 201203,China.
  • Zhang JH; Institute of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine Tianjin 300193,China.
  • Liu JP; Center for Evidence-based Medicine,Beijing University of Chinese Medicine Beijing 100029,China.
  • Yang ZQ; the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510407,China.
  • Cao JL; Dongzhimen University,Beijing University of Chinese Medicine Beijing 100700,China.
  • Liao X; Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences Beijing 100700,China.
  • Xi XY; the Research Center of National Drug Policy&Ecosystem,China Pharmaceutical University Nanjing 211198,China.
  • Han M; Center for Evidence-based Medicine,Beijing University of Chinese Medicine Beijing 100029,China.
  • Li WY; Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Qiu ZW; the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510407,China.
  • Feng SY; the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510407,China.
  • Guo YY; Dongfang Hospital,Beijing University of Chinese Medicine Beijing 100078,China.
  • Cao LJ; Institute of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine Tianjin 300193,China.
  • Liao XH; the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510407,China.
  • Ai YL; Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Huang J; Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Jia LL; Beijing Children's Hospital,Capital Medical University Beijing 100045,China.
  • Su XF; China Association of Chinese Medicine Beijing 100029,China.
  • Wu X; Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences Beijing 100700,China.
  • Dai ZQ; Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences Beijing 100700,China.
  • Guo JH; China Association of Chinese Medicine Beijing 100029,China.
  • Lu BQ; Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Zhang XX; China Association of Chinese Medicine Beijing 100029,China.
  • Tang JY; Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
Zhongguo Zhong Yao Za Zhi ; 48(1): 256-264, 2023 Jan.
Article in Zh | MEDLINE | ID: mdl-36725278
Currently,the research or publications related to the clinical comprehensive evaluation of Chinese patent medicine are increasing,which attracts the broad attention of all circles. According to the completed clinical evaluation report on Chinese patent medicine,there are still practical problems and technical difficulties such as unclear responsibility of the evaluation organization,unclear evaluation subject,miscellaneous evaluation objects,and incomplete and nonstandard evaluation process. In terms of evaluation standards and specifications,there are different types of specifications or guidelines with different emphases issued by different academic groups or relevant institutions. The professional guideline is required to guide the standardized and efficient clinical comprehensive evaluation of Chinese patent medicine and further improve the authority and quality of evaluation. In combination with the characteristics of Chinese patent medicine and the latest research achievement at home and abroad,the detailed specifications were formulated from six aspects including design,theme selection,content and index,outcome,application and appraisal,and quality control. The guideline was developed based on the guideline development requirements of China Assoication of Chinese medicine. After several rounds of expert consensus and public consultation,the current version of the guideline has been developed.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Drugs, Chinese Herbal / Medicine, Chinese Traditional Type of study: Diagnostic_studies / Evaluation_studies / Guideline / Health_technology_assessment Country/Region as subject: Asia Language: Zh Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Drugs, Chinese Herbal / Medicine, Chinese Traditional Type of study: Diagnostic_studies / Evaluation_studies / Guideline / Health_technology_assessment Country/Region as subject: Asia Language: Zh Year: 2023 Type: Article